The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.

Macular degeneration is a prevalent eye disorder that typically results in loss of vision in individuals who are 50 years of age and older. Although there isn’t a recognized cure for this ...

Age-related macular ... them as eye drops to mice with induced dry AMD. The treated group exhibited retinal cell protection and significantly reduced retinal degeneration, comparable to normal ...

Age-related macular ... them as eye drops to mice with induced dry AMD. The treated group exhibited retinal cell protection and significantly reduced retinal degeneration, comparable to normal ...

Age-related macular ... them as eye drops to mice with induced dry AMD. The treated group exhibited retinal cell protection and significantly reduced retinal degeneration, comparable to normal ...

left eye closed, are all those lines quite straight?” On completion of the scans and tests, he said: “You have early age-related macular degeneration.” When he saw my face fall, he added ...

Another common early symptom is blurry or distorted vision. Straight lines, like those on a doorframe or a tiled floor, may ...

This is also called age-related macular degeneration (AMD), as the ... Biomedical Therapeutics and the USC Roski Eye Institute advancing a new treatment for one of the leading causes of blindness ...

Age-related macular degeneration (AMD), which affects about 200 million people worldwide and can result in legal blindness, impairs an area of the eye (retina) used for reading, driving and many other ...

The phase 1 clinical trial is a multicenter, open-label, dose-escalation study to assess drug safety via intravitreal ...

The adenine base editor corrected the most common mutation associated with Stargardt disease in the ABCA4 gene with no ...

Health scientists from the University of Virginia have found a previously unknown contributor to harmful blood vessel growth ...